Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Infectious Disease

Long-Term Monitoring and Living with DILS

At a Glance

Long-term DILS care is individualized: keep HIV suppressed with antiretroviral therapy, monitor the organs affected at diagnosis, protect oral health when dry mouth persists, and report new neurologic symptoms or rapidly changing one-sided gland swelling.

Living with Diffuse Infiltrative Lymphocytosis Syndrome (DILS) means managing a chronic condition that requires consistent, long-term attention. While the initial diagnosis can be overwhelming, the outlook for people on effective Antiretroviral Therapy (ART) is generally improved [1].

Because DILS is a multisystem disorder, your health “maintenance” will involve more than just checking your viral load; it requires monitoring based on your specific baseline findings and symptoms [2].

Your Long-Term Monitoring Plan

There is no universally established DILS monitoring schedule, so your doctor will tailor your follow-ups based on which organs were affected at diagnosis. However, most patients can expect a monitoring plan that includes:

  • HIV Viral Load and CD4/CD8 Counts: These are the most important labs. You want to see your viral load stay “undetectable.” In DILS, doctors may also watch the absolute CD8 count. The CD4:CD8 ratio can remain abnormal despite effective ART and is not a validated measure of DILS activity; it does not have to reach a normal balance as an expected treatment target [3][4].
  • Kidney Health Checks: Regular creatinine blood tests and urinalysis (urine tests) check for protein or blood, which can be early signs of kidney stress. These are guided by symptoms and prior involvement [4][5].
  • Lung Function: If you have had lung involvement (like LIP), your doctor may order Pulmonary Function Tests (PFTs) or chest imaging (like a CT scan). However, imaging and PFT frequency depends on baseline abnormalities, symptoms, and specialist judgment, rather than routine CT scans for everyone [2][6].
  • Neurological Exams: Your doctor will check for new numbness, tingling, or facial weakness during your regular visits [2].

What is the Long-Term Outlook?

For many patients, DILS can be treated effectively. When HIV is suppressed with ART, the immune activation typically decreases [4].

  • Recovery Timeline: Improvement is rarely overnight. While ART often helps, response and timeline vary, and your own clinician must interpret your prognosis. The swelling in your salivary glands or the dryness in your mouth may persist despite viral suppression [4][7].
  • Life Expectancy: Modern ART substantially improves life expectancy for people with HIV, but outcomes vary with comorbidities, immune status, access to care, organ involvement, and treatment response; DILS-specific evidence is limited [1].
  • Malignancy Risk: While DILS itself is not a premalignant condition, people with chronic HIV and immune activation have a slightly higher risk of developing several malignancies, including lymphoma [8]. If you notice a salivary gland or lymph node that is growing rapidly, feels very hard, or is only on one side, prompt clinical assessment is needed. Imaging and needle or tissue sampling will be chosen by the clinician when indicated, rather than prespecifying a biopsy [8][9].

Protecting Your Oral Health

The “sicca” (dryness) symptoms of DILS are often the most persistent long-term challenge. Saliva is your mouth’s natural defense against cavities and infection [10].

Without enough saliva, you are at high risk for:

  1. Rampant Cavities: Especially along the gumline and on the roots of the teeth [11].
  2. Oral Thrush: A fungal infection that causes white patches or a burning sensation in the mouth [12].
  3. Gum Disease: Which can lead to tooth loss if not treated [10].

Actionable Step: See a dentist based on your individualized risk (which may be every 3 to 4 months). Use high-fluoride toothpaste (often prescription-strength) only as directed, limit sugary drinks, and consider using saliva substitutes or sugar-free gum with xylitol to keep your mouth moist [11][13].

Emotional Well-being

It is normal to feel anxious about having a rare complication. Consider tracking a practical follow-up worksheet where you can record your viral load, CD4 count, medications, dry-mouth severity, dental appointments, and new symptoms to discuss.

Seek options for HIV-informed counseling, peer support, and help with treatment access. Support can address the fear, stigma, or daily burden of visible parotid swelling and severe dryness. By staying on your ART and attending your monitoring appointments, you are taking the most powerful steps possible to protect your long-term health.

Common questions in this guide

What tests are used to monitor DILS over time?
DILS monitoring is individualized according to the organs affected and your symptoms. It may include HIV viral load, CD4 and CD8 counts, kidney tests such as creatinine and urinalysis, and lung function tests or chest imaging when the lungs have been involved. Regular visits may also include checks for new neurologic symptoms.
Can HIV treatment improve DILS symptoms?
Antiretroviral therapy suppresses HIV and usually reduces the immune activation linked with DILS. Improvement may take time, and salivary gland swelling or dry mouth can continue even when the viral load is suppressed.
What does an abnormal CD4:CD8 ratio mean in DILS?
The CD4:CD8 ratio can remain abnormal even when antiretroviral therapy is working. It is not a validated measure of DILS activity, so it does not need to return to a normal balance as an expected treatment goal.
How can I protect my mouth and teeth if DILS causes dry mouth?
Dry mouth raises the risk of cavities, oral thrush, and gum disease. Individualized dental visits, high-fluoride toothpaste when directed, limiting sugary drinks, and saliva substitutes or sugar-free gum with xylitol may help protect your mouth.
When should persistent parotid swelling be checked for lymphoma?
Contact your clinician promptly if a salivary gland or lymph node grows quickly, becomes very hard, or is swollen on only one side. The clinician will decide whether imaging, a needle sample, or tissue sampling is needed.
What new symptoms should I report between DILS follow-up visits?
Report new numbness, tingling, facial weakness, balance changes, night sweats, unexplained weight loss, or fevers that differ from your usual symptoms. Also tell your clinician if your dry mouth is worsening or your HIV medicines are difficult to take consistently.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How often should we check my absolute CD8 count and CD4:CD8 ratio to ensure the inflammation is subsiding?
  2. 2.Given that DILS can affect the kidneys, what specific urine tests (like protein-to-creatinine ratio) should I have at my follow-ups?
  3. 3.Are my current breathing tests (PFTs) normal, and when should we repeat them to monitor for lung infiltration?
  4. 4.What is my current viral load, and is it low enough to expect my DILS symptoms to start improving?
  5. 5.If my parotid swelling doesn't go down or if it becomes lopsided, what is the next step to rule out lymphoma?
  6. 6.Can you recommend a dentist who is familiar with managing severe dry mouth in patients with HIV?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Diffuse connective tissue disorders in HIV-infected patients.

    Christoforidou A, Galanopoulos N

    Mediterranean journal of rheumatology 2018; (29(3)):148-155 doi:10.31138/mjr.29.3.148.

    PMID: 32185316
  2. 2

    The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review.

    Ghrenassia E, Martis N, Boyer J, et al.

    Journal of autoimmunity 2015; (59()):19-25.

    PMID: 25660200
  3. 3

    Initial Management of Patients with HIV Infection.

    Goldschmidt RH, Chu C, Dong BJ

    American family physician 2016; (94(9)):708-716.

    PMID: 27929247
  4. 4

    [Efficacy of highly active antiretroviral therapy alone in the treatment of diffuse lymphocytic infiltration syndrome in an ivorian patient living with HIV: a case report].

    Cherif I, Tsevi YM, Bawe LD, et al.

    Medecine tropicale et sante internationale 2021; (1(3)) doi:10.48327/mtsibulletin.2021.118.

    PMID: 35686173
  5. 5

    HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment.

    Rosenberg AZ, Naicker S, Winkler CA, Kopp JB

    Nature reviews. Nephrology 2015; (11(3)):150-60 doi:10.1038/nrneph.2015.9.

    PMID: 25686569
  6. 6

    Microbiome profiling reveals gut bacterial species associated with rapid lung function decline in people with HIV.

    Bai X, Raju SC, Knudsen AD, et al.

    Frontiers in immunology 2025; (16()):1555441 doi:10.3389/fimmu.2025.1555441.

    PMID: 40557154
  7. 7

    Risk of Diffuse Infiltrative Lymphocytosis Syndrome in HIV-Infected Patients: A Nationwide Population-Based Cohort Study.

    Chen M, Yen YF, Lan YC, et al.

    Journal of acquired immune deficiency syndromes (1999) 2018; (79(2)):158-163 doi:10.1097/QAI.0000000000001802.

    PMID: 29995702
  8. 8

    Benign lymphoepithelial cysts of parotid and submandibular glands in a HIV-positive patient.

    Shivhare P, Shankarnarayan L, Jambunath U, Basavaraju SM

    Journal of oral and maxillofacial pathology : JOMFP 2015; (19(1)):107 doi:10.4103/0973-029X.157213.

    PMID: 26097320
  9. 9

    HIV-associated benign lymphoepithelial cysts of the parotid glands confirmed by HIV-1 p24 antigen immunostaining.

    Sekikawa Y, Hongo I

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-221869.

    PMID: 28963391
  10. 10

    The role of natural salivary defences in maintaining a healthy oral microbiota.

    Lynge Pedersen AM, Belstrøm D

    Journal of dentistry 2019; (80 Suppl 1()):S3-S12 doi:10.1016/j.jdent.2018.08.010.

    PMID: 30696553
  11. 11

    Dental demineralization and caries in patients with head and neck cancer.

    Deng J, Jackson L, Epstein JB, et al.

    Oral oncology 2015; (51(9)):824-31.

    PMID: 26198979
  12. 12

    Common Oral Conditions: A Review.

    Stoopler ET, Villa A, Bindakhil M, et al.

    JAMA 2024; (331(12)):1045-1054 doi:10.1001/jama.2024.0953.

    PMID: 38530258
  13. 13

    MASCC/ISOO Clinical Practice Statement: Management of salivary gland hypofunction and xerostomia in cancer patients.

    Hong C, Jensen SB, Vissink A, et al.

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2024; (32(8)):548 doi:10.1007/s00520-024-08688-9.

    PMID: 39048728

This page explains long-term monitoring and daily care for DILS for informational purposes only and does not replace medical advice. Your HIV clinician, specialists, and dentist should tailor testing and treatment to your health.

Get notified when new evidence is published on diffuse infiltrative lymphocytosis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.